Edwards Lifesciences Corporation (NYSE:EW) Receives Average Recommendation of "Moderate Buy" from Brokerages

Edwards Lifesciences Corporation (NYSE:EW) has received an average “Moderate Buy” recommendation from 28 brokerages, with an average 12-month price target of $95.65. This follows strong Q1 earnings, where the company beat EPS and revenue estimates and provided optimistic FY2026 and Q2 guidance. Despite recent insider stock sales totaling $7.12 million, institutional investors hold a significant 79.46% of the company’s stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin